TL;DR: England Launches Mental Health Diagnosis Review Amid Rising Demand
Health Secretary Wes Streeting has announced an independent review to address the surge in mental health, ADHD, and autism diagnoses in England. The review will explore whether increased cases reflect over-diagnosis or unmet needs and will identify gaps in care, diagnostic thresholds, and alternative support systems.
• ADHD medication prescriptions rose 65% from 2019-2024.
• Experts are divided, citing increased awareness, under-diagnosis, or over-medicalization as key factors.
• Findings, due in 2026, aim to improve care through informed policies and potential integration of AI for diagnostic efficiency.
Want health-optimized experiences? Explore healthy dining options with MELA AI’s directory for tailored well-being solutions.
In a groundbreaking announcement, Health Secretary Wes Streeting has called for an independent review into the rising demand for mental health, ADHD, and autism diagnoses in England. The review reflects concerns over whether the sharp increase is driven by over-diagnosis or unmet societal and individual needs. With long waiting times for therapy and diagnosis and a surge in people seeking support, the review aims to evaluate gaps in care and the potential causes behind these trends.
Why the Review Matters: The Rise in Diagnoses
The increase in cases of ADHD and mental health diagnoses over the past two decades raises critical questions. NHS data shows a 65% rise in ADHD medication prescriptions from 2019 to 2024, as reported by the National Institute for Health and Care Excellence. Rates of broader mental health challenges have escalated significantly, with adults reporting symptoms at nearly double the figures from previous decades.
Experts attribute these spikes to various factors:
- Greater awareness of mental health and neurodevelopmental issues.
- Social determinants like poverty, insecurity, isolation, and educational pressures.
- Increased access and recommendation for diagnostics and therapies.
At the same time, some claim the surge reflects over-diagnosis, where behaviors within the spectrum of “normal” are being medicalized. Earlier statements by Wes Streeting suggested a concern about the over-labeling of conditions, especially among younger demographics. However, others argue that issues of under-diagnosis, particularly in marginalized groups, play a larger role in the overloaded system.
What Will the Review Examine?
The review, led by psychologist Professor Peter Fonagy, has been tasked with investigating:
- Whether diagnostic thresholds are appropriate or overly lenient.
- The drivers behind the spike in referrals.
- The gaps in early intervention and ongoing support for those diagnosed.
- Alternative support systems for those who require help but do not meet clinical thresholds for diagnosis.
The findings, expected in summer 2026, are anticipated to inform key policy decisions and resource allocation, reshaping the national approach to mental health and neurodevelopmental care.
Public Reactions to Diagnosis Trends
Diverse reactions have emerged over whether over-diagnosis or under-diagnosis is the real crisis. According to clinicians and organizations advocating for patients, children who were underdiagnosed in earlier decades are now struggling with severe challenges as adults. Professor Tamsin Ford of Cambridge University has spoken out strongly, stating, “We risk denying vital care by framing this as an over-diagnosis issue. Much of the evidence supports widespread under-diagnosis and unmet needs.”
Others, including healthcare professionals, stress the increasing demands of diagnostic services. London GP Professor Sir Sam Everington noted the growing pressure on the NHS, pointing out that referrals are often made without addressing socio-environmental factors that could remedy a patient’s distress without medical treatment.
The Cultural Shift in Diagnostics and Care
Increased awareness has brought both positive outcomes and dilemmas. On one hand, stigmas surrounding mental health and ADHD have significantly lessened, enabling more individuals to seek help. But critics argue that societal and digital influences, including “diagnosis shopping” and the amplification of conditions via social media, contribute to over-diagnosis concerns. This places immense strain on the already overburdened NHS system.
Charities such as Mind and the National Autistic Society emphasize that whether trends stem from misdiagnosis or real needs, better support systems are crucial. Long waiting lists for ADHD diagnoses and mental health therapy leave many feeling abandoned.
How Technology and AI Could Address Diagnostic Pressures
Interestingly, the rising role of technology offers hope. AI tools have begun supporting clinicians in streamlining diagnosis and monitoring patients. These tools could help distinguish between cases requiring direct intervention versus those better suited for socio-behavioral or lifestyle changes. This integration of technology into health evaluation might alleviate resource bottlenecks in the long run.
For instance, platforms like MELA AI, known for matching individuals with health-optimized resources in the dining sector, could serve as an influence on how technology addresses personalization and need-matching in healthcare contexts. As MELA AI connects individuals to restaurants offering tailored meal options, similar AI systems could help match patients to the most appropriate diagnostic and therapeutic pathways in mental health services.
What’s Next for Policy and Care?
Mental health, ADHD, and neurodevelopmental conditions are undeniably complex and deeply entangled with social, economic, and clinical factors. While the review may not resolve every challenge, it could mark the beginning of a more considered and equitable approach to diagnostics, care provision, and public health policymaking.
With gaps in care and growing frustration about overstretched systems, this review offers much-needed hope for reform. As support systems expand and improve alongside smarter technologies, the future may hold a better balance between heightened awareness and structured, effective medical support.
Looking for health-optimized experiences beyond healthcare? Explore how MELA AI connects communities in Malta to dining tailored for better well-being. Find out more about customizable restaurant options by tapping into our dining directory today!
Frequently Asked Questions on Wes Streeting’s Review of Mental Health, ADHD, and Autism Diagnostics
Why did Wes Streeting call for an independent review on mental health, ADHD, and autism services?
The review reflects significant concerns about a steady rise in diagnoses of ADHD, mental health issues, and autism. Health Secretary Wes Streeting initiated this study to determine whether the surge is due to genuine unmet needs or over-diagnosis, where normal behaviors are unnecessarily medicalized. Public data shows a 65% increase in ADHD prescriptions (2019-2024) and doubled rates of mental health symptoms compared to earlier decades. The review aims to assess gaps in care, investigate referral drivers, and evaluate threshold adequacy for diagnosis. It responds to growing political and patient pressure to overhaul the overwhelmed NHS system. The findings could reshape government policies and improve both therapy access and diagnosis rationing for vulnerable populations.
Are ADHD and mental health diagnoses increasing due to greater public awareness?
Experts believe that the increase in diagnoses is partly rooted in the growing public awareness of neurodevelopmental conditions and mental health issues. Awareness campaigns and reduced stigmas have encouraged individuals to seek help earlier, leading to more referrals and potentially diagnoses. Social determinants like insecurity, educational pressures, and poverty can also exacerbate personal distress, pushing individuals to seek professional evaluation. However, critics argue that some cases may reflect “over-diagnosis” driven by societal pressures, including misuse of diagnostic labels. Balancing awareness with proper diagnostic thresholds will be one key aspect of the review’s findings.
How does the review address the concern over “over-diagnosis” in England?
One of the main objectives highlighted by Wes Streeting is testing whether diagnostic thresholds and clinical criteria are too lenient, causing unnecessary diagnoses. Critics caution that normal behaviors in young people (especially) might be pathologically labeled. On the other hand, many clinicians strongly rebut this, claiming that widespread under-diagnosis, especially among marginalized and minority groups, actually poses the greater challenge. The review will evaluate diagnostic rigor while consulting experts, patient groups, and longitudinal NHS data to differentiate over-diagnosis claims from genuine unmet needs.
What is the current state of the NHS regarding mental health and ADHD services?
The NHS has struggled to meet the surging demand for diagnostic evaluations and therapies. Long waiting lists, sometimes stretching over two years for conditions like ADHD or mental health challenges, leave many patients without vital support. Clinicians and referral systems are overloaded, leading to bottlenecks in care delivery. Health charities have repeatedly warned that patients feel abandoned by the system, with life-altering delays impacting families and individuals severely. The review will analyze these service gaps, aiming to recommend practical strategies to manage rising pressure effectively.
How can technology like AI help with diagnostic pressures in mental health?
AI offers promising solutions for managing overwhelming diagnostic demand. Tools powered by AI can help streamline initial assessments, identify high-priority cases, and suggest non-medical interventions (e.g., lifestyle improvements) for mild distress or non-clinical concerns. Diagnostic AI could also assist clinicians by standardizing symptom analysis, helping reduce subjective bias in referrals. Platforms like MELA AI, already tailoring resources for improved health and dining in Malta, demonstrate how AI in different sectors can optimize decision-making. Translating this concept into healthcare could alleviate NHS bottlenecks while ensuring personalized patient care pathways.
What role does MELA AI play in improving mental health awareness through lifestyle choices?
MELA AI promotes healthy choices by connecting communities in Malta and Gozo to restaurants offering nutritious and wellness-focused menus. While primarily aimed at improving physical health, the project emphasizes how lifestyle changes, including improved diets, can positively impact mental well-being. The directory ensures communities are well-informed about health-conscious meals, reflecting a broader societal shift emphasizing prevention and wellness. Discover dining tailored to mental and physical benefits by exploring MELA AI’s Malta Restaurant Directory.
How can ADHD services in Malta benefit from systems like MELA AI?
MELA AI could inspire health-focused sectors beyond restaurant directories, including education and therapeutic methods tailored for ADHD and autism. The AI’s ability to match individuals with optimized resources in dining reflects its potential to streamline personalized care options. Restaurants, healthcare facilities, or wellness centers with a focus on ADHD-friendly environments might increasingly use systems like MELA AI to provide transparency and targeted accessibility. If you’re curious about how MELA AI could play a role in assisting ADHD-friendly dining or broader health outcomes, visit MELA AI’s Enhanced Profiles.
Why do marginalized groups believe they face greater under-diagnosis in ADHD and mental health services?
Research indicates that many underprivileged and minority groups experience systemic barriers to diagnoses, from linguistic hindrances to socio-environmental stigmas that prevent individuals from seeking help. Experts argue that ADHD and autism, like depression, disproportionately feature under-diagnosis in these communities, leading to severe challenges in adulthood due to missed early intervention opportunities. The review hopes to explore these discrepancies and design pathways that address equity in diagnostic access effectively.
Can public awareness campaigns solve overstretched NHS systems?
While awareness campaigns have led to more people seeking help, they cannot independently solve NHS bottlenecks without structural change. Mismanaged referrals, lack of diagnostic clarity, and waiting list congestion make awareness programs insufficient for systemic overhaul. Addressing these issues requires resource reallocation, early support mechanisms, and better socio-environmental interventions structured to help distressed individuals before medical escalation. AI-driven platforms (MELA AI) creatively spotlight how informed choice-driven systems alleviate resource stress in parallel sectors like dining.
When will Wes Streeting’s independent review conclude, and what changes can we expect?
The review, spearheaded by psychologist Professor Peter Fonagy, is scheduled to release findings by summer 2026. It’s anticipated that recommendations will reshape mental health and neurodevelopmental care policies, providing actionable changes for the NHS alongside diagnostic refinement. Whether gaps in care, referral handling, or equitable resource distribution dominate the conclusions, public expectations remain focused on better alignment between support mechanisms and patient needs. Improve your understanding of health-focused systems by exploring MELA AI today.
About the Author
Violetta Bonenkamp, also known as MeanCEO, is an experienced startup founder with an impressive educational background including an MBA and four other higher education degrees. She has over 20 years of work experience across multiple countries, including 5 years as a solopreneur and serial entrepreneur. Throughout her startup experience she has applied for multiple startup grants at the EU level, in the Netherlands and Malta, and her startups received quite a few of those. She’s been living, studying and working in many countries around the globe and her extensive multicultural experience has influenced her immensely.
Violetta Bonenkamp’s expertise in CAD sector, IP protection and blockchain
Violetta Bonenkamp is recognized as a multidisciplinary expert with significant achievements in the CAD sector, intellectual property (IP) protection, and blockchain technology.
CAD Sector:
- Violetta is the CEO and co-founder of CADChain, a deep tech startup focused on developing IP management software specifically for CAD (Computer-Aided Design) data. CADChain addresses the lack of industry standards for CAD data protection and sharing, using innovative technology to secure and manage design data.
- She has led the company since its inception in 2018, overseeing R&D, PR, and business development, and driving the creation of products for platforms such as Autodesk Inventor, Blender, and SolidWorks.
- Her leadership has been instrumental in scaling CADChain from a small team to a significant player in the deeptech space, with a diverse, international team.
IP Protection:
- Violetta has built deep expertise in intellectual property, combining academic training with practical startup experience. She has taken specialized courses in IP from institutions like WIPO and the EU IPO.
- She is known for sharing actionable strategies for startup IP protection, leveraging both legal and technological approaches, and has published guides and content on this topic for the entrepreneurial community.
- Her work at CADChain directly addresses the need for robust IP protection in the engineering and design industries, integrating cybersecurity and compliance measures to safeguard digital assets.
Blockchain:
- Violetta’s entry into the blockchain sector began with the founding of CADChain, which uses blockchain as a core technology for securing and managing CAD data.
- She holds several certifications in blockchain and has participated in major hackathons and policy forums, such as the OECD Global Blockchain Policy Forum.
- Her expertise extends to applying blockchain for IP management, ensuring data integrity, traceability, and secure sharing in the CAD industry.
Violetta is a true multiple specialist who has built expertise in Linguistics, Education, Business Management, Blockchain, Entrepreneurship, Intellectual Property, Game Design, AI, SEO, Digital Marketing, cyber security and zero code automations. Her extensive educational journey includes a Master of Arts in Linguistics and Education, an Advanced Master in Linguistics from Belgium (2006-2007), an MBA from Blekinge Institute of Technology in Sweden (2006-2008), and an Erasmus Mundus joint program European Master of Higher Education from universities in Norway, Finland, and Portugal (2009).
She is the founder of Fe/male Switch, a startup game that encourages women to enter STEM fields, and also leads CADChain, and multiple other projects like the Directory of 1,000 Startup Cities with a proprietary MeanCEO Index that ranks cities for female entrepreneurs. Violetta created the “gamepreneurship” methodology, which forms the scientific basis of her startup game. She also builds a lot of SEO tools for startups. Her achievements include being named one of the top 100 women in Europe by EU Startups in 2022 and being nominated for Impact Person of the year at the Dutch Blockchain Week. She is an author with Sifted and a speaker at different Universities. Recently she published a book on Startup Idea Validation the right way: from zero to first customers and beyond, launched a Directory of 1,500+ websites for startups to list themselves in order to gain traction and build backlinks and is building MELA AI to help local restaurants in Malta get more visibility online.
For the past several years Violetta has been living between the Netherlands and Malta, while also regularly traveling to different destinations around the globe, usually due to her entrepreneurial activities. This has led her to start writing about different locations and amenities from the POV of an entrepreneur. Here’s her recent article about the best hotels in Italy to work from.
